Search Results for: mental illness

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, Major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, Major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality.

Major Depressive Disorder Literature
Publication date: Jan 21, 2026 Open Access PDF Concepts Keywords Genes bipolar disorder Healthspan cardiovascular Lengthening GLP-1 Pharmacother glucagon Schizophrenia major depressive disorder metabolism mortality schizophrenia semaglutide type 2 diabetes ... Read more
A whole population-based cohort study of the trajectory of the prevalence and the incidence of mental illness, challenging behaviour, and psychotropic medication prescribing in adults with intellectual disabilities in the Czech Republic between 2010 and 2022.

A whole population-based cohort study of the trajectory of the prevalence and the incidence of mental illness, challenging behaviour, and psychotropic medication prescribing in adults with intellectual disabilities in the Czech Republic between 2010 and 2022.

Autism Literature
Publication date: Nov 24, 2025 It is essential to understand the complex interaction among mental illness, challenging behaviour and psychotropic medication prescribing among adults with intellectual disabilities to help reduce ... Read more